Gene expression differences between enriched normal and chronic myelogenous leukemia quiescent stem/progenitor cells and correlations with biological abnormalities

Journal of Oncology

Volumn , Issue , 2011, Pages

  Affer, M ^a   Dao, S ^b   Liu, C ^b   Olshen, A B ^c   Mo, Q ^b   Viale, A ^b   Lambek, C L ^b   Marr, T G ^d   Clarkson, B D ^b  

^a MAYO CLINIC   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Hiberna Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE;

ARTICLE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROID CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOCYTE; RECEPTOR DOWN REGULATION; STEM CELL; UPREGULATION;

EID: 79955118593     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/798592     Document Type: Article

References (72)

1. Ries L. H. D., Krapcho M., SEER Cancer Statistics Review 19752003 2006 Bethesda, Md, USA US National Cancer Institute
2. De Klein A., Van Kessel A. G., Grosveld G., A celllular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia Nature 1982 300 5894 765 767 (Pubitemid 13224358)
3. Ren R., Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia Nature Reviews Cancer 2005 5 3 172 183 (Pubitemid 40314949)
4. Daley G. Q., Van Etten R. A., Baltimore D., Induction of chronic myelogenous leukemia in mice by the P210(bcr/abl) gene of the Philadelphia chromosome Science 1990 247 4944 824 830
5. Kantarjian H., Sawyers C., Hochhaus A., Guilhot F., Schiffer C., Gambacorti-Passerini C., Niederwieser D., Resta D., Capdeville R., Zoellner U., Talpaz M., Druker B., Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia New England Journal of Medicine 2002 346 9 645 652 (Pubitemid 34815868)
6. O'Brien S. G., Guilhot F., Larson R. A., Gathmann I., Baccarani M., Cervantes F., Cornelissen J. J., Fischer T., Hochhaus A., Hughes T., Lechner K., Nielsen J. L., Rousselot P., Reiffers J., Saglio G., Shepherd J., Simonsson B., Gratwohl A., Goldman J. M., Kantarjian H., Taylor K., Verhoef G., Bolton A. E., Capdeville R., Druker B. J., Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia New England Journal of Medicine 2003 348 11 994 1004 (Pubitemid 36302244)
7. Roche-Lestienne C., Soenen-Cornu V., Grardel-Duflos N., La J. L., Philippe N., Facon T., Fenaux P., Preudhomme C., Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment Blood 2002 100 3 1014 1018 (Pubitemid 34832631)
8. Le Coutre P., Tassi E., Varella-Garcia M., Barni R., Mologni L., Cabrita G., Marchesi E., Supino R., Gambacorti-Passerini C., Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification Blood 2000 95 5 1758 1766 (Pubitemid 30120840)
9. Dingli D., Michor F., Successful therapy must eradicate cancer stem cells Stem Cells 2006 24 12 2603 2610 (Pubitemid 46052998)
10. Graham S. M., Jrgensen H. G., Allan E., Pearson C., Alcorn M. J., Richmond L., Holyoake T. L., Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro Blood 2002 99 1 319 325
11. Clarkson B., Rubinow S., Drewinko B., Humphrey R. M., Growth kinetics in human Leukemia Growth Kinetics and Biochemical Regulation of Normal and Malignant Cells 1977 Baltimore, Md, USA Williams Wilkins 591 628
12. Irizarry R. A., Bolstad B. M., Collin F., Cope L. M., Hobbs B., Speed T. P., Summaries of Affymetrix GeneChip probe level data Nucleic Acids Research 2003 31 4 e15
13. Storey J. D., Xiao W., Leek J. T., Tompkins R. G., Davis R. W., Significance analysis of time course microarray experiments Proceedings of the National Academy of Sciences of the United States of America 2005 102 36 12837 12842 (Pubitemid 41279452)
14. Strife A., Perez A., Lambek C., Wisniewski D., Bruno S., Darzynkiewicz Z., Clarkson B., Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand Cancer Research 1993 53 2 401 409 (Pubitemid 23031856)
15. Holyoake T., Jiang X., Eaves C., Eaves A., Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia Blood 1999 94 6 2056 2064 (Pubitemid 29430422)
16. Bhatia R., Munthe H. A., Williams A. D., Zhang F., Forman S. J., Slovak M. L., Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation Experimental Hematology 2000 28 12 1401 1412 (Pubitemid 32013914)
17. Corbeil D., Rper K., Hellwig A., Tavian M., Miraglia S., Watt S. M., Simmons P. J., Peault B., Buck D. W., Huttner W. B., The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions Journal of Biological Chemistry 2000 275 8 5512 5520 (Pubitemid 30115186)
18. Jankovic V., Ciarrocchi A., Boccuni P., DeBlasio T., Benezra R., Nimer S. D., Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells Proceedings of the National Academy of Sciences of the United States of America 2007 104 4 1260 1265 (Pubitemid 46183992)
19. Kikushige Y., Yoshimoto G., Miyamoto T., Iino T., Mori Y., Iwasaki H., Niiro H., Takenaka K., Nagafuji K., Harada M., Ishikawa F., Akashi K., Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival Journal of Immunology 2008 180 11 7358 7367
20. Georgantas R. W., Tanadve V., Malehorn M., Heimfeld S., Chen C., Carr L., Martinez-Murillo F., Riggins G., Kowalski J., Civin C. I., Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells Cancer Research 2004 64 13 4434 4441 (Pubitemid 38856914)
21. Ivanova N. B., Dimos J. T., Schaniel C., Hackney J. A., Moore K. A., Lemischka I. R., A stem cell molecutar signature Science 2002 298 5593 601 604 (Pubitemid 35215314)
22. Siddall N. A., McLaughlin E. A., Marriner N. L., Hime G. R., The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity Proceedings of the National Academy of Sciences of the United States of America 2006 103 22 8402 8407 (Pubitemid 43838467)
23. Kilroy G. E., Foster S. J., Wu X., Ruiz J., Sherwood S., Heifetz A., Ludlow J. W., Stricker D. M., Potiny S., Green P., Halvorsen Y. D. C., Cheatham B., Storms R. W., Gimble J. M., Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors Journal of Cellular Physiology 2007 212 3 702 709 (Pubitemid 47271882)
24. Ogawa M., Fried J., Sakai Y., Strife A., Clarkson B. D., Studies of cellular proliferation in human leukemia. VI. The proliferative activity, generation time, and emergence time of neutrophilic granulocytes in chronic granulocytic leukemia Cancer 1970 25 5 1031 1049
25. Clarkson B., Strife A., Wisniewski D., Lambek C. L., Liu C., Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies Leukemia 2003 17 7 1211 1262 (Pubitemid 36857334)
26. Pietersen A. M., van Lohuizen M., Stem cell regulation by polycomb repressors: postponing commitment Current Opinion in Cell Biology 2008 20 2 201 207
27. Jamieson C. H. M., Ailles L. E., Dylla S. J., Muijtjens M., Jones C., Zehnder J. L., Gotlib J., Li K., Manz M. G., Keating A., Sawyers C. L., Weissman I. L., Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML New England Journal of Medicine 2004 351 7 657 667 (Pubitemid 39063268)
28. Terskikh A. V., Miyamoto T., Chang C., Diatchenko L., Weissman I. L., Gene expression analysis of purified hematopoietic stem cells and committed progenitors Blood 2003 102 1 94 101 (Pubitemid 36759641)
29. Graf T., Enver T., Forcing cells to change lineages Nature 2009 462 7273 587 594
30. Akel S., Bertolette D., Petrow-Sadowski C., Ruscetti F. W., Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells Platelets 2007 18 8 566 578 (Pubitemid 350179042)
31. Bagg A., Lineage ambiguity, infidelity, and promiscuity in immunophenotypically complex acute leukemias: genetic and morphologic correlates American Journal of Clinical Pathology 2007 128 4 545 548 (Pubitemid 47584430)
32. Clarkson B., Strife A., Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment Leukemia 1993 7 11 1683 1721 (Pubitemid 23347286)
33. Lawrence H. J., Sauvageau G., Humphries R. K., Largman C., The role of HOX homeobox genes in normal and leukemic hematopoiesis Stem Cells 1996 14 3 281 291 (Pubitemid 26161610)
34. Sauvageau G., Lansdorp P. M., Eaves C. J., Hogge D. E., Dragowska W. H., Reid D. S., Largman C., Lawrence H. J., Humphries R. K., Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells Proceedings of the National Academy of Sciences of the United States of America 1994 91 25 12223 12227 (Pubitemid 24368637)
35. Hirvonen H., Hukkanen V., Salmi T. T., Makela T. P., Pelliniemi T. T., Knuutila S., Alitalo R., Expression of L-myc and N-myc proto-oncogenes in human leukemias and leukemia cell lines Blood 1991 78 11 3012 3020
36. Clarkson B. D., Strife A., Wisniewski D., Lambek C., Carpino N., New understanding of the pathogenesis of CML: a prototype of early neoplasia Leukemia 1997 11 9 1404 1428 (Pubitemid 27404379)
37. Ellisen L. W., Carlesso N., Cheng T., Scadden D. T., Haber D. A., The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells EMBO Journal 2001 20 8 1897 1909 (Pubitemid 32397392)
38. Svensson E., Vidovic K., Lassen C., Richter J., Olofsson T., Fioretos T., Gullberg U., Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells Leukemia 2007 21 12 2485 2494 (Pubitemid 350148892)
39. Hosen N., Shirakata T., Nishida S., Yanagihara M., Tsuboi A., Kawakami M., Oji Y., Oka Y., Okabe M., Tan B., Sugiyama H., Weissman I. L., The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis Leukemia 2007 21 8 1783 1791 (Pubitemid 47086767)
40. Herget T., Brooks S. F., Broad S., Rozengurt E., Expression of the major protein kinase C substrate, the acidic 80- kilodalton myristoylated alanine-rich C kinase substrate, increases sharply when Swiss 3T3 cells move out of cycle and enter G Proceedings of the National Academy of Sciences of the United States of America 1993 90 7 2945 2949 (Pubitemid 23113534)
41. Manenti S., Malecaze F., Chap H., Darbon J. M., Overexpression of the myristoylated alanine-rich C kinase substrate in human choroidal melanoma cells affects cell proliferation Cancer Research 1998 58 7 1429 1434 (Pubitemid 28193604)
42. Kittaka N., Takemasa I., Takeda Y., Marubashi S., Nagano H., Umeshita K., Dono K., Matsubara K., Matsuura N., Monden M., Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data European Journal of Cancer 2008 44 6 885 897
43. Menell J. S., Cesarman G. M., Jacovina A. T., McLaughlin M. A., Lev E. A., Hajjar K. A., Annexin II and bleeding in acute promyelocytic leukemia New England Journal of Medicine 1999 340 13 994 1004 (Pubitemid 29157631)
44. Gillette J. M., Chan D. C., Nielsen-Preiss S. M., Annexin 2 expression is reduced in human osteosarcoma metastases Journal of Cellular Biochemistry 2004 92 4 820 832 (Pubitemid 44264271)
45. Beck-Engeser G. B., Lum A. M., Huppi K., Caplen N. J., Wang B. B., Wabl M., Pvt1-encoded microRNAs in oncogenesis Retrovirology 2008 5, article 4
46. Guan Y., Kuo W. L., Stilwell J. L., Takano H., Lapuk A. V., Fridlyand J., Mao J. H., Yu M., Miller M. A., Santos J. L., Kalloger S. E., Carlson J. W., Ginzinger D. G., Celniker S. E., Mills G. B., Huntsman D. G., Gray J. W., Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer Clinical Cancer Research 2007 13 19 5745 5755 (Pubitemid 47583899)
47. Lennon P. A., Abruzzo L. V., Medeiros L. J., Cromwell C., Zhang X., Yin C. C., Kornblau S. M., Konopieva M., Lin P., Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24) Cancer Genetics and Cytogenetics 2007 177 1 37 42 (Pubitemid 47211298)
48. Diaz-Blanco E., Bruns I., Neumann F., Fischer J. C., Graef T., Rosskopf M., Brors B., Pechtel S., Bork S., Koch A., Baer A., Rohr U. P., Kobbe G., von Haeseler A., Gattermann N., Haas R., Kronenwett R., Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase Leukemia 2007 21 3 494 504
49. Weigmann A., Corbeil D., Hellwig A., Huttner W. B., Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells Proceedings of the National Academy of Sciences of the United States of America 1997 94 23 12425 12430 (Pubitemid 27492544)
50. Richardson G. D., Robson C. N., Lang S. H., Neal D. E., Maitland N. J., Collins A. T., CD133, a novel marker for human prostatic epithelial stem cells Journal of Cell Science 2004 117 16 3539 3545 (Pubitemid 39206394)
51. Bhatia M., AC133 expression in human stem cells Leukemia 2001 15 11 1685 1688 (Pubitemid 33061833)
52. Shmelkov S. V., Butler J. M., Hooper A. T., Hormigo A., Kushner J., Milde T., St Clair R., Baljevic M., White I., Jin D. K., Chadburn A., Murphy A. J., Valenzuela D. M., Gale N. W., Thurston G., Yancopoulos G. D., D'Angelica M., Kemeny N., Lyden D., Rafii S., CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors Journal of Clinical Investigation 2008 118 6 2111 2120 (Pubitemid 351872330)
53. Gallacher L., Murdoch B., Wu D. M., Karanu F. N., Keeney M., Bhatia M., Isolation and characterization of human CD34-Lin and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7 Blood 2000 95 9 2813 2820 (Pubitemid 30235890)
54. Lang P., Bader P., Schumm M., Feuchtinger T., Einsele H., Fhrer M., Weinstock C., Handgretinger R., Kuci S., Martin D., Niethammer D., Greil J., Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors British Journal of Haematology 2004 124 1 72 79 (Pubitemid 38021625)
55. Shultz L. D., Lyons B. L., Burzenski L. M., Gott B., Chen X., Chaleff S., Kotb M., Gillies S. D., King M., Mangada J., Greiner D. L., Handgretinger R., Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R mice engrafted with mobilized human hemopoietic stem cells Journal of Immunology 2005 174 10 6477 6489 (Pubitemid 40663843)
56. Wagner W., Ansorge A., Wirkner U., Eckstein V., Schwager C., Blake J., Miesala K., Selig J., Saffrich R., Ansorge W., Ho A. D., Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis Blood 2004 104 3 675 686 (Pubitemid 38970560)
57. Ghaffari S., Wu H., Gerlach M., Han Y., Lodish H. F., Daley G. Q., BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells Proceedings of the National Academy of Sciences of the United States of America 1999 96 23 13186 13190
58. Graham S. M., Vass J. K., Holyoake T. L., Graham G. J., Transcriptional analysis of quiescent and proliferating CD34+ human hemopoietic cells from normal and chronic myeloid leukemia sources Stem Cells 2007 25 12 3111 3120 (Pubitemid 350294437)
59. Fisher B., Fisher E. R., Experimental evidence in support of the dormant tumor cell Science 1959 130 3380 918 919
60. Burns F. J., Tannock I. F., On the existence of a G 0 -phase in the cell cycle Cell and Tissue Kinetics 1970 3 4 321 334
61. Huang X., Cho S., Spangrude G. J., Hematopoietic stem cells: generation and self-renewal Cell Death and Differentiation 2007 14 11 1851 1859 (Pubitemid 350011661)
62. Clarkson B., Strife A., Fried J., Sakai Y., Ota K., Ohkita T., Masuda R., Studies of cellular proliferation in human leukemia. IV. Behavior of normal hemotopoietic cells in 3 adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days Cancer 1970 26 1 1 19
63. Clarkson B., Ota K., Ohkita T., O'Connor A., Kinetics of proliferation of cancer cells in neoplastic effusions in man Cancer 1965 18 10 1189 1213
64. Sheehy P. F., Fried J., Dowling M. D., Clarkson B. D., Studies of cellular proliferation in human leukemia. VIII. The generation time and growth fraction in lymphosarcoma in a leukemic phase during advanced and early relapsing disease Cancer 1975 36 1 203 210
65. Clarkson B., Clarkson B., Baserga A. R., The survival value of the dormant state in neoplastic and normal cell populations Control of Proliferation in Animal Cells 1974 New York, NY, USA Cold Spring Harbour Laboratory 945 972
66. Wisniewski D., Strife A., Berman E., Clarkson B., c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia Leukemia 1996 10 2 229 237
67. Carpino N., Wisniewski D., Strife A., Marshak D., Kobayashi R., Stillman B., Clarkson B., p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells Cell 1997 88 2 197 204
68. Brehme M., Hantschel O., Colinge J., Kaupe I., Planyavsky M., Kcher T., Mechtler K., Bennett K. L., Superti-Furga G., Charting the molecular network of the drug target Bcr-Abl Proceedings of the National Academy of Sciences of the United States of America 2009 106 18 7414 7419
69. Schindler T., Bornmann W., Pellicena P., Miller W. T., Clarkson B., Kuriyan J., Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase Science 2000 289 5486 1938 1942
70. Strife A., Wisniewski D., Liu C., Lambek C. L., Darzynkiewicz Z., Silver R. T., Clarkson B., Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between kit ligand and cytokines in primary primitive progenitor cells Molecular Cancer Research 2003 1 3 176 185 (Pubitemid 36330199)
71. Liang X., Hajivandi M., Veach D., Wisniewski D., Clarkson B., Resh M. D., Pope R. M., Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells Proteomics 2006 6 16 4554 4564 (Pubitemid 44336971)
72. Bhatia R., Holtz M., Niu N., Gray R., Snyder D. S., Sawyers C. L., Arber D. A., Slovak M. L., Forman S. J., Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment Blood 2003 101 12 4701 4707 (Pubitemid 36857723)